Casey Hoyt - 17 Jan 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role: Chief Executive Officer, Director
Signature: /s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol: VMD
Transactions as of: 17 Jan 2024
Net transactions value: -$280,283
Form type: 4
Filing time: 19 Jan 2024, 17:49:40 UTC
Previous filing: 16 Aug 2023
Next filing: 26 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VMD	Common Shares	Options Exercise		+10,017	+7.1%		150,685	17 Jan 2024	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	$74,026	-10,017	-6.6%	$7.39	140,668	17 Jan 2024	Direct	F2
transaction	VMD	Common Shares	Options Exercise		+40,069	+28%		180,737	17 Jan 2024	Direct	F3
transaction	VMD	Common Shares	Tax liability	$98,708	-13,357	-7.4%	$7.39	167,380	17 Jan 2024	Direct	F2, F4
transaction	VMD	Common Shares	Options Exercise		+14,114	+8.4%		181,494	18 Jan 2024	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	$107,549	-14,114	-7.8%	$7.62	167,380	18 Jan 2024	Direct	F5
holding	VMD	Common Shares						2,010,943	17 Jan 2024	by Elizabeth Rose Homes LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VMD	Phantom Share Units	Options Exercise		-10,017	-33%		20,034	17 Jan 2024	Common Shares	10,017		Direct	F1, F6
transaction	VMD	Restricted Stock Units	Options Exercise	$0	-40,069	-33%	$0.000000	80,136	17 Jan 2024	Common Shares	40,069		Direct	F3, F7
transaction	VMD	Phantom Share Units	Options Exercise		-14,114	-50%		14,114	18 Jan 2024	Common Shares	14,114		Direct	F1, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2	Per share value is based on the market closing price of the common shares for January 17, 2024.
F3	Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F4	Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F5	Per share value is based on the market closing price of the common shares for January 18, 2024.
F6	Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7	Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F8	Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.